[45Ti]Ti-DOTA: En route towards aza-macrocyclic 45Ti-based radiopharmaceuticals

22 April 2024, Version 2
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

We report the first use of DOTA as a chelator for titanium. The resulting complex is fully characterized and extended to the radiolabelling of DOTA with titanium-45.

Keywords

titanium-45
DOTA

Supplementary materials

Title
Description
Actions
Title
Supplementary information
Description
Methods, DFT calculations, Characterization data, Spectra
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.